JPRN-UMIN000001230未知未知
Secondary Prevention of Cerebral Infarction Epidemiological Study on Cerebral Microbleeds - SCIENCE Study
SCIENCE Study Protocol Comittee0 个研究点目标入组 4,000 人开始时间: 2008年7月2日最近更新:
适应症
试验速览
- 阶段
- 未知
- 发起方
- 入组人数
- 4,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 40years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •recurred symptomatic cerebral infarction medicatin of antiplatelet drugs before onset moyamoya disease, AVM, AN, dural AVF previous cerebral contusion previous craniotomy and/or burr hole surgery future surgery and/or intervention for brain and heart previous symptomatic cerebral hemorrhage, other hemorrhagic disease, coagulopathy present malignancy platelet count<10000/m3 liver dysfunction (AST>100IU/L, ALT>100IU/L) renal dysfunction (Cre>3mg/dl) future moving, diffculties for follow-up amyloid angiopathy participants in other intervening clinical research
研究者
相似试验
进行中（未招募）
不适用
Prevention of one sort of cerebral vascular stroke (small subcortical strokes) in patients who already suffered one beforeEUCTR2005-003242-34-ESational Institutes of Neurological Disorders: Stroke2,500
已完成
不适用
Primary prevention of cerebrovascular and cardiovascular events with an oral antidiabetic agent in patients with type 2 diabetes at high risk for cerebral infarctioType 2 DiabetesJPRN-UMIN000000846PROFIT-J Study Steering Committee500
招募中
不适用
Prevention of secondary stroke by risk factor control and medication adherenceCTRI/2021/10/037432Department of Health and Family Welfare
进行中（未招募）
1 期
Prevention of Stroke in Survivors of Brain Bleeding with Atrial FibrillatioEUCTR2018-002176-41-ITImperial College of Science, Technology and Medicine654
进行中（未招募）
不适用
Prevention of cerebrovascular and cardiovascular Events of ischaemic origin with teRutroban in patients with a history oF ischaemic strOke or tRansient ischaeMic attack.The PERFORM Study.An international, randomised, double-blind, two parallel group study comparing terutroban 30 mg o.d. versus aspirin 100 mg o.d. administered orally for a 3-year mean duration (event driven trial). - PERFORMIschaemic stroke or transient ischaemic attackMedDRA version: 7.0Level: PTClassification code 10008190EUCTR2005-003700-10-BEInstitut de Recherches Internationales Servier18,000